Welcome to our online store!

Imatinib Grindex 120 capsules 100mg Leukaemia Иматиниб Гриндекс

Product sku: MD3212

Availability: In stock

Only 20 left


Quick Overview

Cancer, Leukaemia treatment


Imatinib Indications

- first time diagnosed with positive (Ph +) (with the presence of Philadelphia chromosomes white blood cells (bcr-abl)) chronic myeloid leukemia (CML) for which bone marrow transplantation is not considered as the first line of therapy;
- (Ph + CML) in the chronic phase after an unsuccessful interferon alpha therapy either in the acceleration phase or in the phase of the blast crisis;
- positive acute lymphoblastic leukemia (Ph + GLL) with the presence of Philadelphia chromosomes in leukocytes;
- acute lymphoblastic leukemia (Ph + GLL) in the stage of recurrence or difficult to treat;
- myelodysplastic / myeloproliferative diseases (MDS / MPZ);
- hyperozinophilic syndrome (HES) and / or chronic eosinophilic leukemia (HEL) with gene rearrangement of FIP1L1-PDGFRα;
- Kit (CD117) -positive inoperable and / or metastatic malignant gastrointestinal stromal tumors (GIST);
- high risk of recurrence of Kit (CD117) -positive malignant gastrointestinal stromal tumors (GIST) after resection (patients with - - low or minimal risk may not receive adjuvant therapy);
- inoperative dermatitis (DESP) and adult patients with recurrent and / or metastatic dermatophyrosis (DESP) that can not be surgically removed.


Hypersensitivity to the active substance or auxiliary substances that are part of the drug.

Dosage & Administration

Treatment is prescribed by a physician experienced in the treatment of patients with malignant hematologic diseases and malignant tumors.

The drug is used internally during a meal, drinking plenty of water to minimize the risk of gastrointestinal complications. The drug at doses of 400-600 mg is used once a day, while the daily dose of 800 mg should be used on 400 mg twice a day, in the morning and in the evening.

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.